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After the 2003 outbreak of severe acute respiratory syndrome (SARS), the Hong 
Kong SAR Government earmarked a one-off grant of $500 million to support 
research into emerging infectious diseases. Of this, $50 million was used to 
support infectious disease research in the Mainland through the Chinese Ministry 
of Science and Technology. The remaining $450 million was directed to support 
local investigator–initiated research and commissioned projects through the 
creation of the Research Fund for the Control of Infectious Diseases (RFCID).
 The RFCID aims to encourage, facilitate, and support research on the 
prevention, treatment, and control of infectious diseases, in particular emerging 
infectious diseases such as SARS and avian influenza A (H5N1). The Fund is 
administered by the Research Office of the Food and Health Bureau (FHB).
 The RFCID considers funding applications for research studies relevant to 
the control of infectious diseases in the areas of:
• Aetiology, epidemiology, and public health;
• Basic research;
• Clinical and health services research; and
• Enhancement of research infrastructure.
 Thematic priorities for the Fund are set by the FHB and are reviewed regularly 
with input from the Centre for Health Protection (CHP) of the Department 
of Health. Preferential funding is given to research studies that fall under the 
thematic priorities.
 The RFCID supports studies initiated by individual investigators in addition 
to those commissioned by the FHB. The latter address specific health problems, 
fill scientific gaps, and respond to public threats or needs.
 Four commissioned projects totalling $93.2 million have been approved/
earmarked:
• $30 million approved for The University of Hong Kong (HKU) to undertake a 
5-year portfolio of basic laboratory, epidemiology and public health research, 
as well as upgrade its bio-safety level 3 (BL-3) laboratory with enhancement 
for animal experimentation.
• $25 million approved for The Chinese University of Hong Kong (CUHK) 
to undertake a 5-year portfolio of clinical trial and public health research in 
emerging infectious diseases.
• $8.2 million approved for the Hospital Authority (HA) to undertake a portfolio 
of research over 2 years on nosocomial infection and long-term follow-up of 
SARS patients.
• $30 million earmarked for the CHP of the Department of Health over 5 years 
to address important topics in the prevention and control of communicable 
diseases.
The University of Hong Kong
In October 2003, the HKU was invited to submit proposals for research related 
to basic laboratory, epidemiological and public health research in emerging 
infectious diseases. The University was invited to participate because of its 
pioneering work in discovering the SARS-coronavirus, its outstanding work 
on avian influenza A (H5N1) involving research and surveillance, and its track 
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record of peer-reviewed publications, especially in journals 
with high impact factors.
 In October 2003, the HKU submitted its proposal titled 
“Research preparedness for emerging and potentially re-
emerging infectious diseases in Hong Kong”. The objectives 
of the proposal were:
(1) To set up a research team of epidemiologists and 
microbiologists supported by a BL-3 laboratory to 
conduct research on the control of potential locally re-
emerging infections;
(2) To provide the logistic and research capability for an 
immediate response to emerging infectious diseases 
through the synthesis of microbiology, clinical medicine, 
and public health epidemiology.
Under this proposal two main projects were envisaged: 
• Part A: an epidemiology team under the School of 
Public Health, Faculty of Medicine, headed by Prof TH 
Lam and Prof GM Leung.
• Part B: a microbiology team under the Department of 
Microbiology, Faculty of Medicine which would be 
directly in charge of the BL-3 laboratory, and headed by 
Prof JSM Peiris and Prof Y Guan.
Part A: Epidemiology of emerging or potential 
emerging infections
Infectious disease research at the HKU is aimed at 
characterising the patterns of distribution and prevalence 
of infectious diseases and the factors responsible for these 
patterns, and at identifying and testing prevention and 
treatment measures. The commissioned study aimed to 
strengthen the research and development infrastructure 
for infectious disease epidemiology and control, advanced 
data analysis as well as disease modelling and risk 
communication research.
Part B: Microbiology and bio-safety level 3 
laboratory capability
The Department of Microbiology at the HKU played 
a key role in the response to the 2003 SARS outbreak, 
as well as avian influenza A (H5N1) incidents in 1997 
and subsequently. While these efforts are nationally and 
internationally recognised and acclaimed, they highlighted 
the need to strengthen aspects of infrastructure so as to 
enhance responses to future outbreaks. Areas to target 
included the need to upgrade and enhance BL-3 biohazard 
containment facilities, animal BL-3 biohazard laboratories 
where animal experimentation with hazardous organisms 
can be carried out, the core response for viral diagnosis, and 
enhanced research on the epidemiology and mechanisms 
of antimicrobial resistance. Four priority areas for research 
under these themes were outlined, as follows:
(1) Influenza (establishment of the capability to identify 
influenza viruses with pandemic potential);
(2) SARS (ecology and mechanism of SARS 
transmission);
(3) Rapid diagnostic systems; and
() Multi-drug resistance.
 After thorough peer review by a panel of independent 
external referees, the HKU was commissioned with an 
amount of $30 million to complete at least 27 separate 
studies. The relevant portfolio would cover: basic laboratory, 
epidemiological and public health research in emerging 
infectious diseases ($22 million) and the completion of 
the construction of a BL-3 laboratory ($8 million). The 
commissioned study was due to last 5 years from May 2004. 
Table 1 shows the individual HKU-commissioned projects 
at 31 December 2007.
The Chinese University of Hong Kong
In October 2003, the CUHK was invited to undertake a 
portfolio of research on clinical trial and public health 
research on emerging infectious diseases. The CUHK 
was invited to participate, because of its leadership in 
synthesising knowledge on SARS (when knowledge was 
initially non-existent) using bedside observations, clinical 
algorithms, and pragmatic trial approaches. Other reasons 
supporting the ability of the university to carry out such 
work include its outstanding research in hepatitis and related 
diseases, and its track record in peer-reviewed publications 
in high impact journals.
 In October 2003, the CUHK submitted its proposal 
titled “Basic, epidemiological, public health and clinical 
research on emerging infectious diseases”, which initially 
comprised 10 separate projects. In the immediate post-
SARS environment in which the proposal was developed, 
better understanding of the epidemiology, pathogenesis, and 
management of SARS was the most urgent priority. Other 
emerging diseases relevant to Hong Kong would also be 
covered, including tuberculosis, HIV/AIDS, dengue fever, 
and infectious diarrhoea.
 The individual projects proposed by the CUHK aimed 
to develop methods with high sensitivity and specificity for 
the early diagnosis of SARS. Other studies were to address 
why some patients are more susceptible to infection and 
develop more severe illness than others. On the clinical 
front, there would be exploration of new therapies for 
SARS, factors involved in SARS super-spreading events, 
the effectiveness of hospital infection control measures, and 
long-term complications among follow-up SARS patients. 
SARS seroprevalence, environmental factors contributing 
to SARS outbreaks, and psychological and social impacts 
of infectious diseases will also be addressed.
 After thorough peer review by a panel of independent 
external referees, the CUHK was commissioned with an 
amount of $25 million to complete at least 30 separate 
studies in their portfolio of clinical trial and public health 
research on emerging infectious diseases. For administrative 
convenience, the initial 10 research projects and proposals 
submitted subsequently were assigned to three broad 
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Project code Title Principal 
investigator
Status
Part AA: Advanced data analysis and disease modelling
HKU-AA-001 The epidemiology of severe acute respiratory syndrome (SARS) in the 2003 Hong Kong 
epidemic
GM Leung Completed
HKU-AA-002 SARS incubation and quarantine times LM Ho Completed
HKU-AA-003 Case fatality rate with SARS in Hong Kong GM Leung Completed
HKU-AA-004 SARS-coronavirus antibody prevalence in all Hong Kong patient contacts GM Leung Completed
HKU-AA-005 Seroprevalence of SARS-coronavirus in asymptomatic or subclinical population groups GM Leung Completed
HKU-AA-006 Understanding the spatial clustering of SARS in Hong Kong PC Lai Completed
HKU-AA-007 Influenza-associated mortality in Hong Kong CM Wong Completed
HKU-AA-008 A case-crossover study on health impact of influenza circulation measured by weekly 
proportion of positive influenza virus isolations
CM Wong Ongoing
HKU-AA-009 A comprehensive risk assessment of Japanese encephalitis in Hong Kong using 
mathematical modeling
S Riley Completed
HKU-AA-012 Using models to identify routes of nosocomial infection: a large hospital outbreak of 
SARS in Hong Kong
S Riley Completed
HKU-AA-013 Reducing the impact of next influenza pandemic using household-based public health 
interventions
J Wu Completed
HKU-AA-014 Clinical prognostic rules for SARS BJ Cowling Completed
HKU-AA-015 Estimating the incubation distribution of SARS BJ Cowling Completed
HKU-AA-016 Estimating the efficacy of control measures against SARS in Beijing BJ Cowling Ongoing
HKU-AA-017 Comparing the SARS epidemics in Hong Kong, Taiwan and Beijing BJ Cowling Ongoing
HKU-AA-018 Estimating the efficacy of treatments for SARS in Hong Kong BJ Cowling Ongoing
HKU-AA-019 The effectiveness of contact tracing in SARS on infectiousness BJ Cowling Ongoing
HKU-AA-020 Age-period-cohort analysis of tuberculosis notifications in Hong Kong BJ Cowling Ongoing
HKU-AA-021 A robust statistical model of the transmission of SARS in a single residential building 
during the 2003 SARS outbreak in Hong Kong
S Riley Ongoing
Part AB: Risk communication research
HKU-AB-001 Longitudinal assessment of community psycho-behavioral responses during and after 
the 2003 SARS outbreak in Hong Kong
GM Leung Completed
HKU-AB-002 Knowledge of risk and self-protection practices and estimate degree of influenza hazard 
from live animal poultry sales
R Fielding Completed
HKU-AB-003 Avian flu prevention and genetic assortment between H5 and human influenza AJ Hedley Completed
HKU-AB-004 A tale of two cities: community psycho-behavioral surveillance and related impact on 
outbreak control in Hong Kong and Singapore during the SARS epidemic
GM Leung Completed
Part B: Microbiology and bio-safety level 3 laboratory capability
B1: Influenza
HKU-B1-001 The genetic characteristics of H5 subtype influenza viruses of Eurasian lineage HL Chen Ongoing
HKU-B1-002 The genetic origin of H5N1 influenza viruses from poultry in different regions of south 
China
HL Chen Ongoing
HKU-B1-003 The circulation and evolution trend of H9N2 influenza viruses from minor poultry in 
Southern China
HL Chen Ongoing
HKU-B1-004 Receptor for influenza viruses in human cells HL Chen Ongoing
HKU-B1-005 Immunological study of H5N3, a low pathogenic virus, and H5N1, a highly pathogenic 
influenza virus, in mice
Yi Guan Ongoing
HKU-B1-006 Surveillance of wild birds in Mai Po JSM Peiris Ongoing
B2: Severe acute respiratory syndrome (SARS)
HKU-B2-001 The ecology of SARS-coronavirus-related viruses in wild and domestic animals in China HL Chen Ongoing
HKU-B2-002 Establishment of cell culture system for the isolation of SARS-like coronavirus from 
animals: to understand the mechanism of how SARS-like coronavirus gains the ability to 
infect humans
HL Chen Ongoing
HKU-B2-003 Viral loads in clinical specimens and SARS manifestations IFN Hing Completed
HKU-B2-004 Comparative host gene transcription by microarray analysis early after infection of the 
Huh7 cell by SARS-coronavirus and human coronavirus 229E
SF Tang Completed
HKU-B2-005 Clinical features and molecular epidemiology of coronavirus-HKU1-associated 
community acquired pneumonia
CY Woo Completed
B3: Rapid diagnostic systems
HKU-B3-001 Rapid diagnostic system for detection of respiratory pathogens in human clinical 
samples
JSM Peiris Ongoing
B4: Multi-drug resistance
HKU-B4-001 Detection and characterisation of extended-spectrum beta-lactamases among blood 
stream isolates of Enterobacter spp. in Hong Kong
PL Ho Completed
HKU-B4-002 Detection and characterisation of extended-spectrum beta-lactamases among blood 
stream isolates of Proteus mirabilis in Hong Kong
PL Ho Ongoing
HKU-B4-003 Epidemiology of methicillin-resistant Staphylococcus aureus in the Hong Kong 
community
PL Ho Ongoing
HKU-B4-004 Community associated methicillin-resistant Staphylococcus aureus skin and soft tissue 
infections in Hong Kong
PL Ho Ongoing
Table 1. The University of Hong Kong–commissioned study projects at 31 December 2007
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research themes: basic science, clinical studies, and public 
health studies. The commissioned work is due to last 5 
years from June 2004. Table 2 shows the individual CUHK-
commissioned projects at 31 December 2007.
The Hospital Authority Consortium
In December 2003, the HA was invited to submit proposals 
for research related to nosocomial infection and long-term 
follow-up of SARS patients. The HA was invited because:
• The HA has a pool of committed clinicians with proven 
research and publication track records;
• The HA has a unique comprehensive database, derived 
from the Clinical Management System with linkage to 
other relevant information technology systems such as 
those involving pharmacy and pathology laboratories; 
Project code Title Principal 
investigator
Status
Basic science theme
CUHK-BS-001 Molecular epidemiology of SARS-coronavirus infection Dennis YM Lo Completed
CUHK-BS-002 Identification of the cellular receptor of the SARS-coronavirus spike protein Stephen KW Tsui Ongoing
CUHK-BS-003 Immunogenetics study in SARS Nelson LS Tang Completed
CUHK-BS-004 SARS diagnosis, monitoring and prognostication by SARS-coronavirus RNA 
detection
Dennis YM Lo Completed
CUHK-BS-005 Proteomic profiling in SARS: diagnostic and prognostic applications Terence CW Poon Completed
CUHK-BS-006 Investigation of properties of antibody responses in SARS infection Paul KS Chan Completed 
CUHK-BS-007 Small interfering RNA in the prevention and treatment of SARS-coronavirus Joseph JY Sung Completed 
CUHK-BS-008 Subtyping of viral genotypes by mass spectrometry Dennis YM Lo Completed
CUHK-BS-009 Immunogenetics study in tuberculosis Nelson LS Tang Ongoing
CUHK-BS-010 Complete genome sequencing of HIV-1 viruses in Hong Kong Stephen KW Tsui Completed
CUHK-BS-011 Determination of viral load and tissue tropism for fatal SARS-coronavirus infections Paul KS Chan Completed
CUHK-BS-012 The functional roles of 3a in the pathogenesis of SARS Stephen KW Tsui Ongoing
CUHK-BS-013 Unknown viral mutant discovery and simultaneous quantification using base-specific 
cleavage and MALDI-TOF mass spectrometry
CM Ding Completed
CUHK-BS-014 Pathogenesis of avian influenza viruses Paul KS Chan Completed
CUHK-BS-015 Identification of serum proteomic fingerprints for prediction of sepsis in pre-term 
neonates
Dennis YM Lo Completed
CUHK-BS-016 Non-invasive diagnosis of liver cirrhosis in chronic hepatitis B patients by serum total Terence CW Poon Completed
CUHK-BS-017 Analysis of size distributions of HVB DNA in plasma of HBV positive individuals Dennis YM Lo Ongoing
Clinical studies theme
CUHK-CS-001 Long-term sequelae of SARS: physical, neuropsychiatric and quality of life 
assessment
David SC Hui Completed
CUHK-CS-002 Application of personal protective equipments in minimising transmission of 
infectious agents by contract spread in high-risk procedures
Margaret Ip Completed
CUHK-CS-003 Small interfering RNA in the prevention and treatment of SARS-coronavirus Joseph JY Sung Completed
CUHK-CS-004 Correlation of clinical outcome and radiological features in SARS David SC Hui Completed
CUHK-CS-005 SARS-lung function correlation with thin-section computed tomography features 
during convalescent period
David SC Hui Completed
CUHK-CS-007 Natural history of cervicovaginal papillomavirus infections in immunocompetent and 
immunocompromised Chinese women
Edmund Li Ongoing
CUHK-CS-008 Role of cytokines and chemokines in severe and complicated influenza infections Nelson Lee Completed
CUHK-CS-009 Pilot study on the feasibility of fever surveillance in hospital setting KW Choi Completed
CUHK-CS-010 Long term outcome of patients with acute respiratory distress syndrome secondary 
to SARS
David SC Hui Completed
CUHK-CS-011 The risk of oxygen therapy and non-invasive positive pressure ventilation: a pilot 
study
David SC Hui Completed
Public health theme
CUHK-PH-001 Super-spreading events of SARS in hospital setting: who, when and why? Joseph JY Sung Completed
CUHK-PH-002 A comparative study of stigma associated with infectious diseases (SARS, AIDS, 
TB)
Fanny Cheung Completed
CUHK-PH-003 Potential clinical and economic impact of an outreach healthcare service for 
prevention of sexually transmitted diseases in Hong Kong
William Wong Completed
CUHK-PH-004 Bisexuality and HIV-related risk behaviours among men who have sex with men in 
Hong Kong
Joseph TF Lau Completed
CUHK-PH-007 The determination of the prevalence of hepatitis C infection in injection drug users in 
Hong Kong
SS Lee Completed
CUHK-PH-008 A study of behaviour, attitudes and knowledge regarding antibiotic use in the 
community of Sydney and Hong Kong
SS Lee Completed
CUHK-PH-010 A population-based study of acute gastrointestinal illness-burden, associated risk 
factors and social economic impact
Suzanne Ho Ongoing
CUHK-PH-011 Spatiotemporal analysis of heroin addiction and associated infection risks in Hong 
Kong
SS Lee Ongoing
CUHK-PH-012 The changing pattern of hepatitis E infection in Hong Kong Paul KS Chan Ongoing
CUHK-PH-013 Acute gastroenteritis in the elderly homes of Hong Kong: a case-control study Suzanne Ho Ongoing
Table 2. The Chinese University of Hong Kong–commissioned study projects at 31 December 2007
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• The HA has an established forum, called the Collaborative 
Research Group on SARS, to facilitate collaborative 
research and cross-fertilisation of ideas with partners 
including the Hong Kong Polytechnic University, the 
Hong Kong University of Science and Technology, and 
the HKU.
 In January 200, the HA submitted 1 detailed research 
proposals. These were broadly divided into clinical 
studies and nosocomial studies. The Bureau convened 
an independent Assessment Panel comprising leading 
local health professionals. After external peer review 
and assessment, eight proposals worth $8.2 million were 
approved. A project manager based in the HA and supported 
by the Fund coordinated all projects.
 The approved projects are detailed in Table 3. The HA 
Head Office coordinated the participation of relevant public 
hospitals. All projects received ethical approval prior to 
commencement from the relevant institutional review board 
of academic institutions and the appropriate HA cluster. 
Progress was monitored by the FHB’s Research Office.
 Upon completion, the HA reviewed the results of 
the individual studies and submitted a proposal on how 
the findings could be implemented within the context 
of its operations and function. The final reports and 
implementation proposal were reviewed by the Assessment 
Panel and comments and suggestions fedback to the HA for 
their consideration. Further studies may be conducted with 
the mutual consent of HA and the FHB. Table 3 shows the 
individual HA-commissioned projects.
Centre for Health Protection
The Research Council administering the RFCID earmarked 
$30 million to the CHP of the Department of Health to 
conduct research, in collaboration with local, Pearl River 
Delta Region and overseas institutions, to address important 
topics on the prevention and control of communicable 
diseases. In January 2005, the CHP was invited to undertake 
a portfolio of research on the following:
• Cost-effectiveness of primary prevention of infections 
covered (or potentially covered) by the immunisation 
programme (cost-effectiveness theme);
• Surveillance, epidemiology and public health control 
of infections with a regional/cross-border significance 
(public health theme); and
• Prevention of spread of health care–associated infections 
in community settings (nosocomial theme).
 The CHP were invited to participate because of the 
following reasons:-
(1) The central role of the CHP in enhancing existing disease 
control and addressing new threats and its commitment 
to applied research;
(2) The use of a Board of Scientific Advisors and Scientific 
Committees to advise and coordinate activity on varying 
aspects of infectious diseases;
(3) The existence of the Public Health Services Branch 
to undertake surveillance, treatment, health education, 
public health management and regional/international 
liaison; and
(4) CHP’s connections with regional and international 
health authorities and agencies.
Project No. Title Principal investigator / 
institution
Status
Clinical studies
HA-CS-001 Data cleaning, maintenance and analysis of the HA SARS Collaborative Groups 
(HASCOG) Database
Edwina Shung / Hospital 
Authority Head Office
Completed
HA-CS-002a Use of magnetic resonance imaging for screening for avascular necrosis post-
SARS
Ernest MK Yuen / Tuen 
Mun Hospital
Completed
HA-CS-002b Use of magnetic resonance imaging to screen for avascular necrosis post-
SARS: the effects of corticosteroids on avascular necrosis of bones
Yok Lam Kwong / Queen 
Mary Hospital 
Completed
HA-CS-002c Use of magnetic resonance imaging for screening for avascular necrosis post-
SARS: MRI screening for avascular necrosis in atypical pneumonia
Gregory E Antonio / 
Prince of Wales Hospital
Completed
HA-CS-003 Preparation for a multi-centre, double-blinded, randomised, placebo-controlled 
trial on the efficacy of lopinavir / ritonavir plus ribavirin in the treatment of SARS
Wai Cho Yu / Princess 
Margaret Hospital
Completed
Nosocomial studies
HA-NS-001 Source profiling of biohazardous aerosols in hospitals Ming Fang / University of 
Science and Technology
Completed
HA-NS-002 Understanding droplets due to nebuliser and respiratory activities Yuguo Li / University of 
Hong Kong
Completed
HA-NS-003 Evaluating factors that affect ventilation effectiveness in SARS wards Yuguo Li / University of 
Hong Kong
Completed
HA-NS-004 Controlling infectious bioaerosols at source by novel local exhaust ventilation 
devices
Joseph KC Kwan / 
University of Science and 
Technology
Completed
HA-NS-005 An evaluation of nursing practice models in the context of SARS: a clinical trial E Angela Chan / Hong 
Kong Polytechnic 
University
Completed
Table 3. Commissioned projects conducted by the Hospital Authority Consortium
RFCID-commissioned studies
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Project No. Title Principal investigator / 
institution
Status
Cost-effectiveness theme
CHP-CE-02 Economic analysis of Haemophilus influenzae b, chickenpox, pneumococcal, 
hepatitis A and combination vaccines in the Childhood Immunisation Programme 
in Hong Kong
SM McGhee / University 
of Hong Kong
Ongoing
CHP-CE-03 Effectiveness of vaccinating children in reducing influenza among household 
contacts: a community-based, randomised, placebo-controlled trial
GM Leung / University of 
Hong Kong
Ongoing
CHP-CE-04 Economic evaluation of routine childhood influenza vaccine in Hong Kong Edmund AS Nelson / 
Chinese University of 
Hong Kong
Ongoing
CHP-CE-05 Modelling the potential impact of HPV vaccination on Hong Kong’s cervical 
cancer burden
GM Leung / University of 
Hong Kong
Ongoing
Public health theme
CHP-PH-01 Improving HIV surveillance in Hong Kong through molecular characterisation with 
a regional perspective
Wilina WL Lim / Centre 
for Health Protection
Ongoing
CHP-PH-02 Evaluation of the T.Spot-TB test in the targeted screening of close contacts of 
smear-positive tuberculosis patients
CC Leung / Shau Kei 
Wan Jockey Club Clinic 
Ongoing
CHP-PH-04 Comparison of T.Spot-TB and QuantiFERON-TB Gold test with tuberculin test in 
the targeted screening of HIV-infected subjects in Hong Kong
CC Leung / Shau Kei 
Wan Jockey Club Clinic
Ongoing
Table 4. Centre for Health Protection–commissioned projects at 31 December 2007
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Fig. Research areas of individual projects commissioned by the Food and Health Bureau
* Includes studies on non-SARS coronaviruses, influenza-like illness, rhinovirus, bocavirus, etc
† HIV denotes human immunodeficiency virus, STI sexually transmitted infections, and HPV human papillomavirus 
‡ Pathogens causing diseases outside these categories (eg gastroenteritis, methicillin-resistant Staphylococcus aureus, Proteus spp, 
Enterobacter spp, etc)
 In April 2005, the first batch of proposals was 
submitted. Further proposals will be submitted at regular 
intervals thereafter. After thorough peer review by a panel 
of independent external referees, four projects worth $5.1 
million were approved and commenced in December 2005. 
Subsequently, three projects worth $9.27 million were 
approved and are due to commence in 2008. It should be 
noted that the CHP is not primarily a research organisation 
and that the majority of research proposals submitted 
are collaborations with academic institutions and public 
health organisations, with sufficient research capacity 
and capability to ensure the successful completion of the 
proposed projects. Table 4 shows the individual CHP-
commissioned projects at 31 December 2007.
Distribution of projects
As at 31 December 2007, the four commissioned studies 
comprised 91 separate projects reflecting the specific 
research aims of the Hong Kong SAR Government. As 
Collins et al
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the commissioned studies were initiated in the post-SARS 
period, in which the major public concern was the re-
emergence of the disease, the majority (3/91, 0%) of 
projects were directly concerned with its ecology, natural 
history, prevalence, transmission, detection, treatment, and 
control. As southern China is considered a hotspot for the 
evolution of influenza viruses, another prominent research 
area of direct relevance to public health in Hong Kong 
was the surveillance of influenza and the monitoring of its 
potential to evolve into a pandemic strain (13/91, 1%). 
Other areas of interest included infection control, especially 
in hospital ward settings, and studies on viral hepatitis. The 
subject areas of the 91 separate projects are summarised in 
the Figure.
Conclusion
The FHB has commissioned a series of long-term studies to 
research various aspects of the control of infectious diseases 
in Hong Kong, particularly those that have the potential to 
re-emerge. The majority of these commissioned projects 
are completed. Several individual projects have already 
produced valuable information and the results have been 
published in peer-reviewed scientific journals. In addition, 
the results of several studies are available on the Research 
Fund Secretariat website http://www.fhb.gov.hk/grants.
